Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic

NCT04933981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1587

Last updated 2024-04-08

No results posted yet for this study

Summary

Residents in nursing homes for the senior citizens (NH) are at high risk for death from COVID-19. We investigated whether repeated non-mandatory RT-PCR SARS-CoV-2 surveillance of NH staff and visitors reduces COVID-19 incidence rates in NH residents and allows to reduce visiting restrictions.

Conditions

Interventions

DIAGNOSTIC_TEST

Nasopharyngeal swab for SARS-CoV-2

in the interventional group, regular, i.e. twice to three times weekly, SARS-CoV-2 testing was offered to health-care workers and visitors of nursing homes

Sponsors & Collaborators

  • City Council of Cologne, Department of Public Health, NRW, Germany

    collaborator UNKNOWN
  • City Council of Cologne, Department of Social Affairs, Health and Environment, NRW, Germany

    collaborator UNKNOWN
  • University of Cologne

    lead OTHER

Principal Investigators

  • Oliver A Cornely, MD · University of Cologne

Eligibility

Min Age
0 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2020-12-15
Completion
2021-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04933981 on ClinicalTrials.gov